IBDEI1BI ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21303,0)
 ;;=I48.0^^70^913^47
 ;;^UTILITY(U,$J,358.3,21303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21303,1,3,0)
 ;;=3^Atrial Fibrillation,Paroxysmal
 ;;^UTILITY(U,$J,358.3,21303,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,21303,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,21304,0)
 ;;=I49.9^^70^913^50
 ;;^UTILITY(U,$J,358.3,21304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21304,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,21304,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,21304,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,21305,0)
 ;;=I42.9^^70^913^51
 ;;^UTILITY(U,$J,358.3,21305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21305,1,3,0)
 ;;=3^Cardiomyopathy,Unspec
 ;;^UTILITY(U,$J,358.3,21305,1,4,0)
 ;;=4^I42.9
 ;;^UTILITY(U,$J,358.3,21305,2)
 ;;=^5007200
 ;;^UTILITY(U,$J,358.3,21306,0)
 ;;=I50.42^^70^913^53
 ;;^UTILITY(U,$J,358.3,21306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21306,1,3,0)
 ;;=3^Chr Combined Systolic & Diastolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,21306,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,21306,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,21307,0)
 ;;=I50.32^^70^913^54
 ;;^UTILITY(U,$J,358.3,21307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21307,1,3,0)
 ;;=3^Chr Diastolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,21307,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,21307,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,21308,0)
 ;;=I27.82^^70^913^55
 ;;^UTILITY(U,$J,358.3,21308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21308,1,3,0)
 ;;=3^Chr Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,21308,1,4,0)
 ;;=4^I27.82
 ;;^UTILITY(U,$J,358.3,21308,2)
 ;;=^338238
 ;;^UTILITY(U,$J,358.3,21309,0)
 ;;=I50.22^^70^913^57
 ;;^UTILITY(U,$J,358.3,21309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21309,1,3,0)
 ;;=3^Chr Systolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,21309,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,21309,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,21310,0)
 ;;=I42.0^^70^913^60
 ;;^UTILITY(U,$J,358.3,21310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21310,1,3,0)
 ;;=3^Dilated Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,21310,1,4,0)
 ;;=4^I42.0
 ;;^UTILITY(U,$J,358.3,21310,2)
 ;;=^5007194
 ;;^UTILITY(U,$J,358.3,21311,0)
 ;;=I10.^^70^913^62
 ;;^UTILITY(U,$J,358.3,21311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21311,1,3,0)
 ;;=3^Essential Hypertension
 ;;^UTILITY(U,$J,358.3,21311,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,21311,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,21312,0)
 ;;=I50.9^^70^913^67
 ;;^UTILITY(U,$J,358.3,21312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21312,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,21312,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,21312,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,21313,0)
 ;;=I35.1^^70^913^76
 ;;^UTILITY(U,$J,358.3,21313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21313,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,21313,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,21313,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,21314,0)
 ;;=I35.0^^70^913^77
 ;;^UTILITY(U,$J,358.3,21314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21314,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,21314,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,21314,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,21315,0)
 ;;=I35.2^^70^913^78
 ;;^UTILITY(U,$J,358.3,21315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21315,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
